Bell’s palsy and urticarial rash as fi rst manifestations of COVID-19 infection
https://doi.org/10.30629/2658-7947-2021-26-3-46-50
Abstract
The new coronavirus SARS-CoV-2 is a single-stranded RNA virus of the Coronaviridae family and is clinically manifest with respiratory symptoms. However, patients have been described with symptoms and complications from the nervous system, as well as skin manifestations in the form of various rashes. In our clinical case of coronavirus infection (SARS-CoV-2), this is pneumonia with respiratory failure of the 1st degree, moderate severity and Bell’s palsy in combination with skin rashes in the form of an urticarial rash in a 58-year-old woman. Clinical features of cutaneous and neurological symptoms were prior to the development of respiratory symptoms. The presented clinical case showed that COVID-19, before the development of respiratory symptoms, can manifest itself with peripheral paralysis of the facial nerve and be combined with skin rashes, which can complicate the timely diagnosis of a viral disease.
About the Authors
Kh. P. DerevyankoRussian Federation
Ufa
L. N. Khusainova
Russian Federation
Ufa
M. M. Khafizov
Russian Federation
Ufa
A. Sh. Sattarova
Russian Federation
Ufa
Sh. M. Safin
Russian Federation
Ufa
References
1. World Health Organization. 11 march 2020. httph://www.int/ru/dg/speeches/detail/who-director-general-s-opening-remarks-atthe-media-briefingon-covid-19
2. Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J. et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil. Med. Res. 2020;13:11. https://doi.org/10.1186/s40779-020-00240-0
3. Zhao Y., Zhao Z., Wang Y., Zhou Y., Ma Y., Zuo W. Single-cell RNA expression profi ling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv published online, 2020. https://doi.org/10.1101/2020.01.26.919985
4. Zhai P., Ding Y., Wu X., Long J., Zhong Y., Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int. J. Antimicrob. Agents. 2020;28:105955. https://doi.org/10.1016/j.ijantimicag.2020.105955
5. Carlos W.G., Dela Cruz C.S., Cao B., Pasnick S., Jamil S. Novel Wuhan (2019-nCoV) coronavirus. Am. J. Respir. Crit. Care Med. 2020;201:7–8. https://doi.org/10.1164/rccm.2014P7
6. Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020;109:12–15. https://doi.org/10.1016/j.jaut.2020.102433
7. Belopasov V.V., Yachou Y., Samoilova E.M., Baklaushev V.P. The nervous system damage in COVID-19. Journal of Clinical Practice. 2020;11(2):60–80. (In Russian). https://doi.org/10.17816/clinpract34851
8. Ternovyh I.K., Topuzova M.P., Chaykovskaya A.D., Isabekova P.S., Alekseeva T.M. Neurological manifestations and complications in patients with COVID-19. Translational Medicine. 2020;7(3):21–29. (In Russian) https://doi.org/10.18705/2311-4495-2020-7-3-21-29.
9. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507–513. https://doi.org/10.1016/S0140-6736 (20)30211-7
10. Guan W., Ni Z., Hu Y., Liang W., Ou C., He J. et al. Clinical characteristics of 2019 novel coronavirus infection in China. https://doi.org/10.1101/2020.02.06.20020974
11. Chen C., Dong Y., Kang J., Lou Sh., Wan F., Liu H. et al. Asymptomatic novel coronavirus pneumonia presenting as acute cerebral infarction: case report and review of the literature. Chin. J. Emerg. Med. 2020,29 (00):E017–E017. https://doi.org/10.3760/cma.j.issn.1671-0282.2020022.007
12. Zhao N., Fu L. The fi rst case report of 2019-nCoV pneumonia complicated with encephalitis. Available from: http://china.caixin.com/2020-03-09/101525701.html
13. Deng S.Q., Peng H.J. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J. Clin. Med. 2020;9(2):575. https://doi.org/10.3390/jcm9020575
14. Peitersen E. Bell’s Palsy: The spontaneous course of 2500 peripheral facial nerve palsies of diff erent etiologies. Acta Oto-Laryngologica. 2002;7:4–30. PMID:12482166
15. Greco A., Gallo A., Fusconi M., Marinelli C., Macri G.F. Vincentiis M. Bell’s palsy and autoimmunity. Autoimmunity reviews. 2012;12:323–328. https://doi.org/10.1016/j.autrev.2012.05.008
16. Murakami S., Mizobuchi M., Nakashiro Y., Doi T., Hato N., Yanagihara N. Bell palsy and herpes simplex virus: identifi cation of viral DNA in endoneurial fl uid and muscle. Ann. Intern. Med. 1996124 (1Pt.1):27–30. https://doi.org/10.7326/0003-4819-124-1_part_1-199601010-00005
17. Minnerop M., Herbst M., Fimmers R., Kaabar P., Matz B., Klockgether T. et al. Bell’s palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J. Neurol. 2008;255:1726–1730. https://doi.org/10.1007/s00415-008-0008-6
18. Rahimi H., Tehranchinia Z. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19. BioMed Research International. 2020;1236520:8. https://doi.org/10.1155/2020/1236520
19. Galván Casas C., Català A., Carretero Hernández G., Rodríguez‐ Jiménez P., Fernández Nieto D., Rodríguez‐Villa Lario A. et al. Classifi cation of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br. J. Dermatol. 2020;183(1):71–77. Epub 2020 Jun 10. https://doi.org/10.1111/bjd.19163
20. Xu J., Zhong S., Liu J., Li L., Li Y., Wu X. et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 2005;41(8):1089–1096. https://doi.org/10.1086/444461
21. Lau K.K., Yu W.C., Chu C.M., Lau S.T., Sheng B., Yuen K.Y. Possible central nervous system infection by SARS coronavirus. Emerg. Infect. Dis. 2004;10(2):342–344. https://doi.org/10.3201/eid1002.030638
22. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, hostvirus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11(7):995–998. https://doi.org/10.1021/acschemneuro.0c00122
23. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J. Med. Virol. 2020;92:552–555. https://doi.org/10.1002/jmv.25728
24. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(suppl 6):683–90. https://doi.org/10.1001/jamaneurol.2020.1127
25. Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A. et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767–83. Published Online July 2, 2020 https://doi.org/10.1016/S1474-4422 (20)30221-0
26. Homma Y., Watanabe M., Inoue K., Moritaka T. Coronavirus Disease-19 Pneumonia with Facial Nerve Palsy and Olfactory Disturbance. Intern. Med. 2020;59(14):1773–1775. https://doi.org/10.2169/internalmedicine.5014-20
27. Islamoglu Y., Celik B., Kiris M. Facial paralysis as the only symptom of COVID-19: A prospective study. Am. J. Otolaryngol. 202142 (4):102956. Published online 2021 Feb 10. https://doi.org/10.1016/j.amjoto.2021.102956
28. Figueiredo R., Falcão V., Pinto M.J., Ramalho C. Peripheral facial paralysis as presenting symptom of COVID-19 in a pregnant woman. BMJ Case Rep. 2020;13(8):e237146. https://doi.org/10.1136/bcr-2020-237146
29. Theophanous C., Santoro J., Itani R. Bell’s palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Brain Dev. 2020:S0387-7604 (20)30260-6. https://doi.org/10.1016/j.braindev.2020.08.017
30. Farber M.A., Farber F.M. Nevropatii licevogo nerva. Alma-Ata: Gylym, 1991:168 (In Russian)
31. Yanagihara N., Mori H., Kozawa T., Nakamura K., Kita M. Bell’s Palsy: Nonrecurrent v Recurrent and Unilateral v Bilateral. Arch. Otolaryngol. 1984;110(6):374–377. https://doi.org/10.1001/archotol.1984.00800320028006
32. McCormick D.P. Herpes-simplex virus as a cause of Bell’s palsy. Lancet. 1972;1:937–939. https://doi.org/10.1016/s0140-6736 (72)91499-7
33. Steiner I. Human herpes viruses latent infection in the nervous system. Immunol. Rev. 1996;152:157–173. https://doi.org/10.1111/j.1600-065x.1996.tb00915.x
34. Leibowitz U. Epidemic incidence of Bell’s palsy. Brain. 1969;92:109–114. https://doi.org/10.1093/brain/92.1.109
35. Liston S.L., Kleid M.S. Histopathology of Bell’s palsy. Laryngoscope. 1989;99:23–26. https://doi.org/10.1288/00005537-198901000-00006
36. Ji X., Zhang C., Zhai Y., Zhang Z., Zhang C., Xue Y. et al. TWIRLS, an automated topic-wise inference method based on massive literature, suggests a possible mechanism via ACE2 for the pathological changes in the human host after coronavirus infection. https://doi.org/10.1101/2020.02.24.20025437
37. Zhang W., Xu L., Luo T., Wu F., Zhao B., Li X. The etiology of Bell’s palsy: a review. J. Neurol. 2019;267:1896–905. https://doi.org/10.1007/s00415-019-09282-4
38. Grattan C.E.H., Marsland A.M. Urticaria: Rook’s Textbook of Dermatology [Internet. Chichester, UK: John Wiley & Sons, Ltd, 2016:1–21].
39. Dvornikov A.S., Silin A.A., Gaydina T.A., Larina V.N., Skripkina P.A., Kiva E.V. The Dermatological Manifestations in the Coronavirus Infection COVID-19. The Russian Archives of Internal Medicine. 2020;10(6):422–429. (In Russian). https://doi.org/10.20514/2226-6704-2020-10-6-422-429.
40. Wedi B., Raap U., Wieczorek D., Kapp A. Urticaria and infections. Allergy Asthma Clin. Immunol. 2009;5(1):10. https://doi.org/10.1186/1710-1492-5-10
41. Hamming I., Timens W., Bulthuis M.L.C., Lely A.T., Navis G.J., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A fi rst step in understanding SARS pathogenesis. J. Pathol. 2004;203(2):631–637. https://doi.org/10.1002/path.1570
42. Mehregan D.R., Gibson L.E. Pathophysiology of urticarial vasculitis. Arch. Dermatol. 1998;134:88–89. https://doi.org/10.1001/archderm.134.1.88
43. Tolouian R., Zununi Vahed S., Ghiyasvand S., Tolouian A., Ardalan M.R. COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment. J. Renal. Inj. Prev. 2020;9(2):e19. https://doi.org/10.34172/jrip.2020.19
44. Nishad A.A.N., Arulmoly K., Priyankara S.A.S., Abeysundara P.K. A forgotten cause of allergy at ER that is still diffi cult to diagnose and treat at poor resource setting: angioedema after using angiotensin converting enzyme inhibitors for 4 years. Case Reports Immunol. 2019;2019:1676391. Published online 2019 Jan 2. https://doi.org/10.1155/2019/1676391
45. Hofman Z.L.M., van den Elzen M.T., Kuijpers J., de Maat S., Hack C.E., Knulst A.C. et al. Evidence for bradykinin release in chronic spontaneous urticaria. Clin. Exp. Allergy. 2020;50(3):343–351. https://doi.org/10.1111/cea.13558
46. Coenraads P.-J., Gonçalo M. Skin diseases with high public health impact. contact dermatitis. Eur. J. Dermatol. 2007;17:564–5. https://doi.org/10.1684/ejd.2007.0299
47. Olasz E.B., Yancey K.B. Bullous pemphigoid and related subepidermal autoimmune blistering diseases. Curr. Dir. Autoimmun. 2008;10:141–66. https://doi.org/10.1159/000131452
48. Mehregan D.R., Hall M.J., Gibson L.E. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J. Am. Acad. Dermatol. 1992;26(3Pt.2):441–8. https://doi.org/10.1016/0190-9622(92)70069-r
49.
Review
For citations:
Derevyanko Kh.P., Khusainova L.N., Khafizov M.M., Sattarova A.Sh., Safin Sh.M. Bell’s palsy and urticarial rash as fi rst manifestations of COVID-19 infection. Russian neurological journal. 2021;26(3):46-50. https://doi.org/10.30629/2658-7947-2021-26-3-46-50
Email this article 